Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation

Description

Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep apnea prevalence of 25% in the general population, and perhaps higher among patients with AF. Home sleep testing is frequently used for evaluation of sleep apnea.

Study Start Date

June 2015

Estimated Completion Date

May 2017

Interventions

  • Device: Home Sleep Testing Device
  • Device: Continuous positive airway pressure ventilation (CPAP)

Specialties

  • Cardiology: Arrhythmias/EP
  • Pulmonology: Apnea/Sleep Disorders

MeSH Terms

  • Apnea
  • Arrhythmias
  • Obstructive

Study ID

Beth Israel Deaconess Medical Center -- Pending

Status

Unknown

Trial ID

NCT02332096

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

100

Sponsor

Beth Israel Deaconess Medical Center

Eligible criteria for the study include: 1. Patients age 18 years and older. 2. Patients with the diagnosis of atrial fibrillation presenting for clinical ablation procedure. Exclusion criteria for the study include: 1. Patients with an existing diagnosis of sleep apnea. 2. Patients who are unable to provide informed consent.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Beth Israel Deaconess Medical Center - Boston, Massachusetts 2.4 miles Elad Anter MD 617-632-9209 eanter@bidmc.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.